APEX1 and lung cancer: Several reports have suggested that APE1 genotypes were not major determinants of lung cancer susceptibility among smokers [85, 86], while several authors have asserted that APE1 polymorphisms such as −656T > G located in the promoter region and D148E could modify the risk of developing lung cancer attributable to cigarette smoking exposure [80–83].